Endobetix endobetix.com


Public lists: Medical Devices (6162)

Endobetix is developing a minimally invasive, nonsurgical implant to treat T2D and obesity that mimics the hormonal benefits offered by bariatric surgery.

Endobetix is developing a minimally invasive, nonsurgical implant to treat T2D and obesity that mimics the hormonal benefits offered by bariatric surgery.

Company (Alive / Active)

Phone: +972-72-260-7000

Fax:

17 Tchelet Street

Misgav, 20174
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Endobetix $0M Oct 12, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Endobetix Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Pancreaticobiliary diversion device Jul 20, 2011 Dec 01, 2015 Patent
Pancreaticobiliary diversion device Jun 05, 2014 Application
Pancreatiobiliary diversion device Jan 17, 2013 Application